Get to know Sara Gandolfi
Passionate and curious about life and science since she was a kid, Sara graduated from Medical School in 2010 at Università degli Studi di Milano. During her clinical Residency in Hematology at Humanitas Research Hospital she accepted the challenge to move to United States and work as a lab scientist, with the goal of acquiring deep knowledge of basic and translational research to improve the treatment of multiple myeloma, a rare and not-yet-curable blood cancer.
She’s now a post-doctoral research fellow at Dana Farber Cancer Institute/Harvard Medical School in Boston, MA and she collaborates with the Broad Institute of Harvard and MIT.
The aim of her project is to study the complex interactions between cancer cells and tumor microenvironment, using sophisticated genome engineering technologies to identify new therapeutic targets. Her project was awarded the AIRC “Fellowship for abroad” and the American Society of Hematology Abstract Achievement Award.
She strongly advocates a modern translational medicine in which lab science and patient care are tightly intertwined and her goal is to bring back to Italy such an approach, along with the knowledge she acquired in the United States.